Spectral AI Inc. Class A Common Stock (MDAI)
Stock · NASDAQ · Health Care
$1.53as of 10/16/2026
Price chart
Active signals
MDAI Signal Track Record
How signals performed across all stocks →What MDAI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 44 | -2.3% | 43% | September 23, 2026 |
| Bollinger Band Breakout | 30 | 0.0% | 47% | September 21, 2026 |
| Bollinger Band Breakdown | 16 | +6.0% | 69% | July 28, 2026 |
| 200-Day Moving Average TouchActive now | 11 | +0.1% | 55% | October 5, 2026 |
| Any 20-session window (baseline) | +0.1% | 50% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MDAI
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds cap…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 65
- Website
- www.spectral-ai.com/
Fundamentals
- 1-day range
- $1.49$1.56
- Market cap
- $52.83M
- P/E (trailing)
- —
- P/E (forward)
- -1.64
- EPS (trailing)
- $-0.34
- Dividend yield
- —
- Beta
- 1.26
- Avg. volume
- 150.2K
How Spectral AI Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Mar 31, 2025 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Spectral AI Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- MDAISpectral AI Inc. Class A Common Stock$1.51▼ 1.95%Market cap $52.83MP/E —$1.18$2.97
- SNWVSANUWAVE Health Inc. Common Stock$4.96▼ 4.06%Market cap $51.59MP/E 3.11$3.92$36.42
- BDMDBaird Medical Investment Holdings Ltd Ordinary Share$0.566▼ 5.67%Market cap $49.81MP/E —$0.5108$3.7
- SKYASkyAI Inc. Common Stock$2.65▼ 3.28%Market cap $49.52MP/E —$0.91$2.77
- SRTSSensus Healthcare Inc. Common Stock$2.77▲ 0.00%Market cap $49.06MP/E —$2.66$5.49
- DRIODarioHealth Corp. Common Stock$4.82▼ 6.04%Market cap $56.88MP/E —$5.03$16.5
- NYXHNyxoah SA Ordinary Shares$1.11▼ 6.72%Market cap $57.20MP/E —$1.11$5.3
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MDAI Spectral AI Inc. Class A Common Stock | $52.83M | — | $1.51 | ▼ 1.95% | $1.18$2.97 |
| SNWV SANUWAVE Health Inc. Common Stock | $51.59M | 3.11 | $4.96 | ▼ 4.06% | $3.92$36.42 |
| BDMD Baird Medical Investment Holdings Ltd Ordinary Share | $49.81M | — | $0.566 | ▼ 5.67% | $0.5108$3.7 |
| SKYA SkyAI Inc. Common Stock | $49.52M | — | $2.65 | ▼ 3.28% | $0.91$2.77 |
| SRTS Sensus Healthcare Inc. Common Stock | $49.06M | — | $2.77 | ▲ 0.00% | $2.66$5.49 |
| DRIO DarioHealth Corp. Common Stock | $56.88M | — | $4.82 | ▼ 6.04% | $5.03$16.5 |
| NYXH Nyxoah SA Ordinary Shares | $57.20M | — | $1.11 | ▼ 6.72% | $1.11$5.3 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView™ SystemYahoo · 10/6/2026
- Spectral AI Announces First Site Initiation Visit for DeepView System™ Clinical Study Supporting Label Expansion Strategy to Burns of the Head, Hands, and FeetYahoo · 10/1/2026
- Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn WoundsYahoo · 9/24/2026
- Spectral AI To Present Data Titled Artificial Intelligence Training & Validation Of Multi-spectral Imaging Device For Evaluation Of Burn Wounds At ACS Clinical Congress 2026Benzinga · 9/24/2026
- Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn ConferenceYahoo · 9/16/2026
Insider Activity
Insider Actions →- John Michael DiMaio · September 28, 2026 · Grant32.0K @ $1.62
- John Michael DiMaio · September 23, 2026 · Grant60.0K @ $1.67
- John Michael DiMaio · September 21, 2026 · Grant21.0K @ $1.69
- John Michael DiMaio · September 18, 2026 · Grant11.0K @ $1.61
- John Michael DiMaio · September 11, 2026 · Grant22.0K @ $1.59
- John Michael DiMaio · September 10, 2026 · Grant10.0K @ $1.56
- John Michael DiMaio · August 13, 2026 · Grant35.0K @ $1.64
- John Michael DiMaio · May 29, 2026 · Grant15.0K @ $2.12
- John Michael DiMaio · May 28, 2026 · Grant2.5K @ $2.36
- John Michael DiMaio · May 26, 2026 · Grant32.2K @ $2.61
- Richard John Cotton · May 18, 2026 · Grant8.8K @ $2.4
- John Michael DiMaio · May 15, 2026 · Grant25.0K @ $2.16
- John Michael DiMaio · May 15, 2026 · Grant1.9K @ $2.12
- Richard John Cotton · May 15, 2026 · Grant5.9K @ $2.33
- John Michael DiMaio · April 24, 2026 · Grant100.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 3.17M
- Total value held
- $4.66M
- Institutional holders
- 22
- Unknown900.0K
- Unknown726.3K
- Unknown301.2K
- Unknown221.0K
- Unknown210.5K
- Unknown199.0K
- Unknown122.3K
- Unknown113.0K
- Unknown87.0K
- Unknown75.6K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Spectral AI to Present Burn Wound Imaging Data at ACS 2026
Spectral AI announced it will present data on using artificial intelligence and multi-spectral imaging to assess burn wounds at the ACS Clinical Congress 2026. This event highlights the company's ongoing clinical validation efforts for its medical device technology. The stock is currently trading near its support level, with analyst targets set significantly higher than the recent price range.
Spectral AI to Present Burn Wound Imaging Data at ACS 2026. Spectral AI announced it will present data on using artificial intelligence and multi-spectral imaging to assess burn wounds at the ACS Clinical Congress 2026. This event highlights the company's ongoing clinical validation efforts for its medical device technology. The stock is currently trading near its support level, with analyst targets set significantly higher than the recent price range.